NCT01888575View on ClinicalTrials.gov

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

CompletedOBSERVATIONAL
Enrollment

35,604

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Cardiovascular Prevention
Interventions
DRUG

Risk of low dose aspirin discontinuation

PPI continuous use; No PPI usePPI

Trial Locations (1)

Unknown

Research Site, Madrid

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY